An observational study in Cerebrovascular Event, Vitamin b12 and Hemorrhagic Stroke, sponsored by Hospital General de Mexicali. Recruiting at 1 site in Mexico. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-01-05.
Sponsored by Hospital General de Mexicali · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Cerebral vascular events (CVA) have a high prevalence in our environment; they are the first cause of disability and the second cause of death in the world (6.6 million deaths). 71% of all strokes worldwide correspond to the ischemic type, which is defined as an infarction in the brain, spinal cord or retina; The remaining 10-40% are hemorrhagic and are due to rupture of cerebral arteries. Until epidemiological week 35 of 2022, 34,643 cases were reported in Mexico, for this week in 2021, 26,462 cases had been reported. Baja California is among the first three places in the country with the highest number of reported cases, the majority corresponding to the male sex. The key clinical characteristic is the sudden appearance of a focal neurological deficit. Imaging studies such as head computed tomography or magnetic resonance imaging allow us to differentiate the subtype and mechanism of CVD since treatment differs markedly between CVD of ischemic origin and that of hemorrhagic origin. Vitamin B12 or cobalamin is a tetrapyrrole cofactor; One of its functions is to participate in the metabolism of homocysteine, which has been reported in various studies and it has been shown that high levels of this increase the risk of vascular diseases, such as stroke. On the other hand, vitamin B12 deficiency can lead to platelet dysfunction, causing significant bleeding. There are few protocols that have sought the direct association of cobalamin with CVD and even fewer with the hemorrhagic type. This condition is one of the main causes of admission to the Emergency Service of the General Hospital of Mexicali where they are given the necessary attention such as performing imaging studies and taking laboratory samples and based on the results the treatment to be followed is decided; However, measurements of vitamin B12 levels are not performed in this population. If the association is demonstrated, it could be implemented as a preventive measure for cerebral vascular events.
General objective: To demonstrate if there is a difference between serum levels of vitamin B12 in patients with hemorrhagic cerebral vascular event compared to patients with ischemic cerebral vascular event.
Specific objectives
STUDY DESIGN This will be a prospective, observational, analytical study of patients admitted to the General Hospital of Mexicali with a diagnosis of ischemic or hemorrhagic stroke.
SOURCE FOR OBTAINING PATIENTS Patients admitted to the adult emergency department of the Mexicali General Hospital with a diagnosis of ischemic or hemorrhagic stroke are included. The information will be collected from the electronic clinical record.
Non-probability sampling for convenience. Select all patients who arrive at the hospital who meet inclusion criteria and do not have any exclusion or elimination criteria.
234 studies on the registry are indexed under Hemorrhagic Stroke; 94 are open to participants now.
This study's planned enrollment of 100 is below the median of 379 across 75 observational studies indexed under Hemorrhagic Stroke.
Browse Hemorrhagic Stroke studies →Hospital General de Mexicali is the lead sponsor of 4 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Select all patients who arrive at the hospital who meet inclusion criteria and do not have any exclusion or elimination criteria.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
measure serum vitamin b12 levels
Diagnostic Test: Measure serum vitamin b12 levels
measure serum vitamin b12 levels
Diagnostic Test: Measure serum vitamin b12 levels
Measure the vitamin b-12 levels in patients that are admitted for stroke of any kind
Difference of vitamin B12 level between ischemic and hemorrhagic stroke
Demonstrate if there is a difference between serum levels of vitamin B12 in patients with hemorrhagic cerebral vascular event compared to patients with ischemic cerebral vascular event.
Time frame: November 2023 - November 2024
Vitamin B12 defficiency in patients with stroke
Vitamin B12 defficiency in patients with any kind of stroke
Time frame: November 2023 - November 2024
Population characteristics
Determine if variables like sex, age, comorbilities and lab tests have a correlation between stroke and Vitamin B12 levels
Time frame: November 2023 - November 2024
Mortality and vitamin B 12 deficiency in this specific population
Analize the levels of vitamin B12 and the in-hospital mortality in this population
Time frame: November 2023 - November 2024
Levels of B12 vitamin and severity of stroke
Analize if there is a significant difference between the levels of B12 and the severity of stroke
Time frame: November 2023 - November 2024
Plan to share: No
Started Nov 2023 (actual). Primary completion is estimated for Jul 2024, 7 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital General de Mexicali